Cathy Klema
Director, PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
Companies
- OptimizeRx CorpBoard member Feb 2, 2024 to now1
- Allergan plcBoard member Oct 3, 2013 to May 2, 20192
- ActavisBoard member May 8, 2006 to Oct 2, 20133
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OptimizeRx Corp OPRX56,137 shares4$496.8K at $8.85Jun 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 9, 2026Granted 34,517 shares of OptimizeRx Corp4
- Jun 11, 2025Granted 9,868 shares of OptimizeRx Corp5
- Feb 2, 2025Exercised options 5,109 shares of OptimizeRx Corp6
- Jun 7, 2024Granted 6,643 shares of OptimizeRx Corp7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROptimizeRx Corp, Board member
- 2SEC EDGARAllergan plc, Board member
- 3SEC EDGARActavis, Board member
- 4
- 5SEC EDGARForm 4 filed Jun 12, 2025
- 6SEC EDGARForm 4 filed Feb 4, 2025
- 7SEC EDGARForm 4 filed Jun 11, 2024